
Avonex Pen
My Prescription
Payment
Select pharmacy



$8,790.64
Print or send this coupon to your phone
About Avonex Pen
Drug Details
This medication is designed for individuals with multiple sclerosis (MS). While it is not a cure for the condition, interferon can help reduce the progression of the disease and lessen the frequency of symptom flare-ups, which may include issues with balance, numbness, or weakness.
Price history for Avonex Pen
1 Auto-injector Kit, 30MCG/0.5ML
Average retail price for Avonex Pen
Average SaveHealth price for Avonex Pen
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Avonex Pen dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 30MCG/0.5ML | 1 Auto-injector Kit | $8,817.81 | $8,817.81 |
| 30MCG/0.5ML | 2 Auto-injector Kits | $17,618.62 | $8,809.31 |
| 30MCG/0.5ML | 3 Auto-injector Kits | $26,419.43 | $8,806.48 |
Avonex Pen FAQs
AVONEX Pen is a pre-filled autoinjector device used to administer AVONEX, which is a form of interferon beta-1a. It is used in the treatment of multiple sclerosis (MS) to help reduce the frequency of relapses and slow the progression of physical disability. The pen allows for easier self-administration of the medication by patients.
The cost of the AVONEX pen can vary depending on factors such as location, insurance coverage, and pharmacy pricing. It is recommended to check with local pharmacies or consult with an insurance provider for the most accurate and up-to-date pricing information. Additionally, some pharmaceutical companies offer patient assistance programs that may help reduce the cost.
Yes, AVONEX is still used as a treatment for multiple sclerosis (MS). It is a form of interferon beta-1a and is used to help reduce the frequency of relapses and slow the progression of physical disability in patients with relapsing forms of MS.